Frontiers in Psychiatry (Dec 2021)
Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics
- Anna Levy,
- Anna Levy,
- Wissam El-Hage,
- Wissam El-Hage,
- Djamila Bennabi,
- Djamila Bennabi,
- Etienne Allauze,
- Etienne Allauze,
- Alexandra Bouvard,
- Alexandra Bouvard,
- Vincent Camus,
- Vincent Camus,
- Philippe Courtet,
- Philippe Courtet,
- Jean-Michel Dorey,
- Jean-Michel Dorey,
- Bruno Etain,
- Bruno Etain,
- Guillaume Fond,
- Guillaume Fond,
- Jean-Baptiste Genty,
- Jean-Baptiste Genty,
- Jérôme Holtzmann,
- Jérôme Holtzmann,
- Mathilde Horn,
- Mathilde Horn,
- Marion Leboyer,
- Marion Leboyer,
- Pierre-Michel Llorca,
- Pierre-Michel Llorca,
- Manon Meyrel,
- Manon Meyrel,
- Fanny Molière,
- Fanny Molière,
- Anne-Sophie Nguon,
- Anne-Sophie Nguon,
- Jean Petrucci,
- Jean Petrucci,
- Romain Rey,
- Romain Rey,
- Raphaelle Richieri,
- Raphaelle Richieri,
- Florian Stephan,
- Florian Stephan,
- Guillaume Vaiva,
- Guillaume Vaiva,
- Guillaume Vaiva,
- Michel Walter,
- Michel Walter,
- Emmanuel Haffen,
- Emmanuel Haffen,
- Bruno Aouizerate,
- Bruno Aouizerate,
- Antoine Yrondi,
- Antoine Yrondi
Affiliations
- Anna Levy
- Fondation FondaMental, Créteil, France
- Anna Levy
- Service de Psychiatrie et de Psychologie Médicale de l'adulte (Department of Psychiatry and Adult Medical Psychology), Centre Expert Dépression Résistante FondaMental (FondaMental Advanced Centre of Expertise in Resistant Depression, CHU de Toulouse (University Hospital Centre), Hôpital Purpan, ToNIC Toulouse NeuroImaging Centre, Université de Toulouse (Toulouse University), INSERM, UPS, Toulouse, France
- Wissam El-Hage
- Fondation FondaMental, Créteil, France
- Wissam El-Hage
- U1253, iBrain, CIC1415, Inserm, CHRU de Tours (Regional University Hospital Centre), Université de Tours, Tours, France
- Djamila Bennabi
- Fondation FondaMental, Créteil, France
- Djamila Bennabi
- Service de Psychiatrie, Centre Expert Dépression Résistante FondaMental, CIC-1431 INSERM, CHU de Besançon, EA 481 Neurosciences, Université de Bourgogne Franche Comté, Besançon, France
- Etienne Allauze
- Fondation FondaMental, Créteil, France
- Etienne Allauze
- Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, EA 7280, Clermont-Ferrand, France
- Alexandra Bouvard
- Fondation FondaMental, Créteil, France
- Alexandra Bouvard
- Pôle de Psychiatrie Générale et Universitaire (Department of General and University Academic Psychiatry Cluster), Centre de référence régional des pathologies anxieuses et de la dépression (Regional Reference Center for the Management and Treatment of Anxiety and Depressive Disorders), Centre Expert Dépression Résistante FondaMental (FondaMental Advanced Centre of Expertise in Resistant Depression), CH Charles Perrens, Bordeaux, Laboratoire Nutrition et Neurobiologie intégrée (Integrated Nutrition and Neurobiology Laboratory) (UMR INRAE 1286), Université de Bordeaux (Bordeaux University), Bordeaux, France
- Vincent Camus
- Fondation FondaMental, Créteil, France
- Vincent Camus
- U1253, iBrain, CIC1415, Inserm, CHRU de Tours (Regional University Hospital Centre), Université de Tours, Tours, France
- Philippe Courtet
- Fondation FondaMental, Créteil, France
- Philippe Courtet
- Department of Emergency Psychiatry and Acute Care, CHU Montpellier, INSERM U1061, Montpellier University, Montpellier, France
- Jean-Michel Dorey
- Fondation FondaMental, Créteil, France
- Jean-Michel Dorey
- INSERM U1028, CNRS UMR5292, University Lyon 1, Lyon Neuroscience Research Centre, Psychiatric Disorders: from Resistance to Response ΨR2 Team, Centre Hospitalier Le Vinatier (Hospital Centre), Bron, France
- Bruno Etain
- Fondation FondaMental, Créteil, France
- Bruno Etain
- Université de Paris et AP-HP - GHU Lariboisière-Fernand Widal - Département de Psychiatrie et de Médecine Addictologique, Paris, France
- Guillaume Fond
- Fondation FondaMental, Créteil, France
- Guillaume Fond
- 0Pôle Psychiatrie, Centre Expert Dépression Résistante FondaMental, CHU La Conception, Marseille, France
- Jean-Baptiste Genty
- Fondation FondaMental, Créteil, France
- Jean-Baptiste Genty
- 1Université Paris-Est, UMR_S955, UPEC, Créteil, France Inserm, U955, Equipe 15 Psychiatrie génétique (Team 15 Genetic Psychiatry), Créteil, France AP-HP, Hôpital H. Mondor-A. Chenevier, Pôle de psychiatrie (Psychiatry Cluster), Créteil, France Fondation FondaMental, Fondation de Cooperation Scientifique (Scientific Cooperation Foundation), Créteil, France
- Jérôme Holtzmann
- Fondation FondaMental, Créteil, France
- Jérôme Holtzmann
- 2Service Hospitalo-Universitaire de Psychiatrie, CHU Grenoble Alpes, Université Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences (Institute of Neurosciences), Grenoble, France
- Mathilde Horn
- Fondation FondaMental, Créteil, France
- Mathilde Horn
- 3Service de Psychiatrie adulte (Department of Adult Psychiatry), Centre Expert Dépression Résistante FondaMental, CHRU de Lille, Hôpital Fontan 1, Lille, France
- Marion Leboyer
- Fondation FondaMental, Créteil, France
- Marion Leboyer
- 1Université Paris-Est, UMR_S955, UPEC, Créteil, France Inserm, U955, Equipe 15 Psychiatrie génétique (Team 15 Genetic Psychiatry), Créteil, France AP-HP, Hôpital H. Mondor-A. Chenevier, Pôle de psychiatrie (Psychiatry Cluster), Créteil, France Fondation FondaMental, Fondation de Cooperation Scientifique (Scientific Cooperation Foundation), Créteil, France
- Pierre-Michel Llorca
- Fondation FondaMental, Créteil, France
- Pierre-Michel Llorca
- Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, EA 7280, Clermont-Ferrand, France
- Manon Meyrel
- Fondation FondaMental, Créteil, France
- Manon Meyrel
- Université de Paris et AP-HP - GHU Lariboisière-Fernand Widal - Département de Psychiatrie et de Médecine Addictologique, Paris, France
- Fanny Molière
- Fondation FondaMental, Créteil, France
- Fanny Molière
- Department of Emergency Psychiatry and Acute Care, CHU Montpellier, INSERM U1061, Montpellier University, Montpellier, France
- Anne-Sophie Nguon
- Fondation FondaMental, Créteil, France
- Anne-Sophie Nguon
- 2Service Hospitalo-Universitaire de Psychiatrie, CHU Grenoble Alpes, Université Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences (Institute of Neurosciences), Grenoble, France
- Jean Petrucci
- Fondation FondaMental, Créteil, France
- Jean Petrucci
- 1Université Paris-Est, UMR_S955, UPEC, Créteil, France Inserm, U955, Equipe 15 Psychiatrie génétique (Team 15 Genetic Psychiatry), Créteil, France AP-HP, Hôpital H. Mondor-A. Chenevier, Pôle de psychiatrie (Psychiatry Cluster), Créteil, France Fondation FondaMental, Fondation de Cooperation Scientifique (Scientific Cooperation Foundation), Créteil, France
- Romain Rey
- Fondation FondaMental, Créteil, France
- Romain Rey
- INSERM U1028, CNRS UMR5292, University Lyon 1, Lyon Neuroscience Research Centre, Psychiatric Disorders: from Resistance to Response ΨR2 Team, Centre Hospitalier Le Vinatier (Hospital Centre), Bron, France
- Raphaelle Richieri
- Fondation FondaMental, Créteil, France
- Raphaelle Richieri
- 0Pôle Psychiatrie, Centre Expert Dépression Résistante FondaMental, CHU La Conception, Marseille, France
- Florian Stephan
- Fondation FondaMental, Créteil, France
- Florian Stephan
- 4Service Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale 29G01 et 29G02 (University Hospital Department of General Psychiatry and Psychosocial Rehabilitation), Centre Expert Depression Résistante FondaMental, EA 7479, CHRU de Brest, Hôpital de Bohars, Brest, France
- Guillaume Vaiva
- Fondation FondaMental, Créteil, France
- Guillaume Vaiva
- 3Service de Psychiatrie adulte (Department of Adult Psychiatry), Centre Expert Dépression Résistante FondaMental, CHRU de Lille, Hôpital Fontan 1, Lille, France
- Guillaume Vaiva
- 5Centre National de Ressources et Résilience pour les psychotraumatismes (Cn2r Lille Paris), Lille, France
- Michel Walter
- Fondation FondaMental, Créteil, France
- Michel Walter
- 4Service Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale 29G01 et 29G02 (University Hospital Department of General Psychiatry and Psychosocial Rehabilitation), Centre Expert Depression Résistante FondaMental, EA 7479, CHRU de Brest, Hôpital de Bohars, Brest, France
- Emmanuel Haffen
- Fondation FondaMental, Créteil, France
- Emmanuel Haffen
- Service de Psychiatrie, Centre Expert Dépression Résistante FondaMental, CIC-1431 INSERM, CHU de Besançon, EA 481 Neurosciences, Université de Bourgogne Franche Comté, Besançon, France
- Bruno Aouizerate
- Fondation FondaMental, Créteil, France
- Bruno Aouizerate
- Pôle de Psychiatrie Générale et Universitaire (Department of General and University Academic Psychiatry Cluster), Centre de référence régional des pathologies anxieuses et de la dépression (Regional Reference Center for the Management and Treatment of Anxiety and Depressive Disorders), Centre Expert Dépression Résistante FondaMental (FondaMental Advanced Centre of Expertise in Resistant Depression), CH Charles Perrens, Bordeaux, Laboratoire Nutrition et Neurobiologie intégrée (Integrated Nutrition and Neurobiology Laboratory) (UMR INRAE 1286), Université de Bordeaux (Bordeaux University), Bordeaux, France
- Antoine Yrondi
- Fondation FondaMental, Créteil, France
- Antoine Yrondi
- Service de Psychiatrie et de Psychologie Médicale de l'adulte (Department of Psychiatry and Adult Medical Psychology), Centre Expert Dépression Résistante FondaMental (FondaMental Advanced Centre of Expertise in Resistant Depression, CHU de Toulouse (University Hospital Centre), Hôpital Purpan, ToNIC Toulouse NeuroImaging Centre, Université de Toulouse (Toulouse University), INSERM, UPS, Toulouse, France
- DOI
- https://doi.org/10.3389/fpsyt.2021.795666
- Journal volume & issue
-
Vol. 12
Abstract
Introduction: Treatment-resistant depression (TRD) is a disabling psychiatric condition characterized by the failure of two antidepressants (ADs). Since the occurrence of side effects (SEs) appears to be one of the main determinants of early discontinuation of pharmacological treatments contributing to a pseudo-resistance, the purpose of this study was to determine the parameters associated with the occurrence of SEs under ADs in a cohort of patients with TRD.Methods: An observational, cross-sectional, multicentre study was carried out using data from the French network of Expert Centers for TRD. For the 108 patients enrolled in the study, the statistical analyses focused on the overall occurrence and on the profile of the SEs (9 categories, 32 items).Results: SEs were influenced by age and sex and were positively associated with the intensity of anxious, depressive and suicidal symptoms, a history of childhood trauma (sexual abuse, emotional abuse and neglect), and negatively associated with self-esteem, and assessment of overall functioning.Conclusion: Using variables accessible in common practice, these results fall within the dynamic of a more tailored approach to medicine that could allow, through integrated pharmacological management, the continuation of antidepressant treatments, and therefore limit the risk of therapeutic failure.
Keywords
- expert centres
- treatment-resistant depression
- antidepressants
- side effects
- clinical severity
- childhood trauma